Windtree Therapeutics, Inc.
WINT
$1.20
-$0.10-7.69%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.88% | -82.15% | 348.58% | 46.82% | -9.10% |
| Total Depreciation and Amortization | 39.09% | 22.46% | -8.70% | -8.33% | 423.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,172.34% | 181.68% | -1,686.87% | -90.67% | -83.45% |
| Change in Net Operating Assets | -830.00% | 1,174.63% | 79.49% | 208.29% | 134.93% |
| Cash from Operations | -67.20% | 33.49% | -16.99% | -5.53% | 5.98% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -97.85% | 100.00% | 7.54% | 37.93% | 38.36% |
| Issuance of Common Stock | -- | -100.00% | 62.16% | -49.43% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,078.97% | -85.13% | 74.96% | -53.32% | -120.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.12% | -110.31% | 0.78% | -34.54% | -39.43% |
